Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors.

by Michael C Burger, Pia S Zeiner, Kolja Jahnke, Marlies Wagner, Michel Mittelbronn, Joachim P Steinbach
Published 2016-01-01

Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma

by Michael W. Ronellenfitsch, Pia S. Zeiner, Michel Mittelbronn, Hans Urban, Torsten Pietsch, Dirk Reuter, Christian Senft, Joachim P. Steinbach, Manfred Westphal, Patrick N. Harter
Published 2018-08-01

Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients

by Pia S. Zeiner, Martina Kinzig, Iris Divé, Gabriele D. Maurer, Katharina Filipski, Patrick N. Harter, Christian Senft, Oliver Bähr, Elke Hattingen, Joachim P. Steinbach, Fritz Sörgel, Martin Voss, Eike Steidl, Michael W. Ronellenfitsch
Published 2019-11-01

DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma

by Bastian Schilling, Sascha Tierling, Jörn Walter, Katharina Filipski, Michael Scherer, Kim N. Zeiner, Andreas Bucher, Johannes Kleemann, Philipp Jurmeister, Tabea I. Hartung, Markus Meissner, Karl H. Plate, Tim R. Fenton, Pia S. Zeiner, Patrick N. Harter
Published 2021-07-01

Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death

by Anna-Luisa Luger, Nadja I. Lorenz, Hans Urban, Iris Divé, Anna L. Engel, Florian Strassheimer, Katja Dettmer, Pia S. Zeiner, Shabnam Shaid, Nina Struve, Malte Kriegs, Ute Hofmann, Peter J. Oefner, Patrick N. Harter, Joachim P. Steinbach, Michael W. Ronellenfitsch
Published 2020-08-01